LIA
ANIK icon

LS Investment Advisors’s Anika Therapeutics ANIK Stock Holding History

LS Investment Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,376
Closed -$52K – 834
2020
Q2 		$52K Hold
1,376
– – ﹤0.01% 1160
2020
Q1 		$40K Hold
1,376
– – ﹤0.01% 1167
2019
Q4 		$71K Buy
+1,376
New +$79.9K ﹤0.01% 1227
2016
Q1 		– Sell
-495
Closed -$19K – 1843
2015
Q4 		$19K Hold
495
– – ﹤0.01% 1493
2015
Q3 		$16K Hold
495
– – ﹤0.01% 1531
2015
Q2 		$16K Buy
+495
New +$17.7K ﹤0.01% 1566

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

LS Investment Advisors's ANIK Position: Q3 2020 in Review

LS Investment Advisors sold out of Anika Therapeutics (ANIK) in Q3 2020, closing a stake of 1,376 shares — an estimated $52K sold.

LS Investment Advisors first reported a position in ANIK in Q2 2015 and held it in 6 quarters. The position peaked at $71K in Q4 2019. 156 funds tracked by Wall St. Rank hold ANIK as of Q3 2020.

  • LS Investment Advisors reported no remaining Anika Therapeutics position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 1,376 Anika Therapeutics shares in Q3 2020, an estimated $52K.
  • LS Investment Advisors first reported a position in Anika Therapeutics in Q2 2015 and held it in 6 quarters.
  • LS Investment Advisors's Anika Therapeutics position peaked at $71K in Q4 2019.
  • 156 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.